Published in Mult Scler on December 01, 2005
TRP channels in lower urinary tract dysfunction. Br J Pharmacol (2014) 1.48
Pannexin 1 involvement in bladder dysfunction in a multiple sclerosis model. Sci Rep (2013) 0.98
Sacral neuromodulation in patients with multiple sclerosis. World J Urol (2011) 0.81
The symptomatic management of multiple sclerosis. Ann Indian Acad Neurol (2009) 0.78
Management of neurogenic bladder in patients with multiple sclerosis. Nat Rev Urol (2016) 0.78
Impact of intermittent catheterization on the quality of life of multiple sclerosis patients. World J Urol (2013) 0.75
Second consensus statement on the diagnosis of multiple system atrophy. Neurology (2008) 7.27
Phosphorylation by p34cdc2 regulates spindle association of human Eg5, a kinesin-related motor essential for bipolar spindle formation in vivo. Cell (1995) 5.68
Consensus statement on the diagnosis of multiple system atrophy. J Neurol Sci (1999) 5.01
Pregnancy disorders that lead to delivery before the 28th week of gestation: an epidemiologic approach to classification. Am J Epidemiol (2008) 3.25
The Concise Guide to PHARMACOLOGY 2013/14: overview. Br J Pharmacol (2013) 2.48
An open-label pilot study of cannabis-based extracts for bladder dysfunction in advanced multiple sclerosis. Mult Scler (2004) 2.15
Tremor after head injury and its treatment by stereotaxic surgery. J Neurol Neurosurg Psychiatry (1982) 1.96
Decreased sensory receptors P2X3 and TRPV1 in suburothelial nerve fibers following intradetrusor injections of botulinum toxin for human detrusor overactivity. J Urol (2005) 1.86
Community-based asthma care: trial of a "credit card" asthma self-management plan. Eur Respir J (1994) 1.76
The role of neuromodulation in the management of urinary urge incontinence. BJU Int (2003) 1.73
Treatment of erectile dysfunction with sildenafil citrate (Viagra) in parkinsonism due to Parkinson's disease or multiple system atrophy with observations on orthostatic hypotension. J Neurol Neurosurg Psychiatry (2001) 1.68
Long-term results of a multicenter study on sacral nerve stimulation for treatment of urinary urge incontinence, urgency-frequency, and retention. Urology (2000) 1.61
Amphotericin-resistant aspergillus osteomyelitis controlled by itraconazole. Lancet (1990) 1.59
The role of the human bladder lamina propria myofibroblast. BJU Int (2003) 1.57
Genitourinary dysfunction in multiple system atrophy: clinical features and treatment in 62 cases. J Urol (1994) 1.55
Osteomyelitis and septic arthritis in children: appropriate use of imaging to guide treatment. AJR Am J Roentgenol (1995) 1.54
Efficacy of sacral nerve stimulation for urinary retention: results 18 months after implantation. J Urol (2001) 1.54
Botulinum toxin for the treatment of lower urinary tract symptoms: a review. Neurourol Urodyn (2005) 1.53
Targeting the kinesin Eg5 to monitor siRNA transfection in mammalian cells. Biotechniques (2002) 1.52
Brain responses to changes in bladder volume and urge to void in healthy men. Brain (2001) 1.50
Treatment of lower urinary tract dysfunction in patients with multiple sclerosis. Committee of the European Study Group of SUDIMS (Sexual and Urological Disorders in Multiple Sclerosis) J Neurol Neurosurg Psychiatry (1992) 1.45
Failure of dithiothreitol and pronase to reveal a false-positive cryptococcal antigen determination in cerebrospinal fluid. Am J Clin Pathol (1991) 1.44
Antigen specificity and cross-reactivity of monoclonal anti-lysozyme antibodies. Mol Immunol (1987) 1.44
Ciprofloxacin as prophylaxis for urinary tract infection: prospective, randomized, cross-over, placebo controlled study in patients with spinal cord lesion. J Urol (1994) 1.43
One question as a screening instrument for depression in people with multiple sclerosis. Clin Rehabil (2007) 1.43
Validation of parachlorobenzotrifluoride, benzotrifluoride, and monochlorotoluene on diffusive samplers. Appl Occup Environ Hyg (2000) 1.41
The 'Queen Square bladder stimulator': a device for assisting emptying of the neurogenic bladder. Br J Urol (1997) 1.40
Veratrine-stimulated phosphoinositide breakdown as an assay for local anesthetic actions at Na+ channels. Anesth Analg (1995) 1.39
Lack of selectivity of URB602 for 2-oleoylglycerol compared to anandamide hydrolysis in vitro. Br J Pharmacol (2006) 1.36
When somatic information threatens, catastrophic thinking enhances attentional interference. Pain (1998) 1.35
Rapid and quantitative detection of enzymatically amplified HIV-1 DNA using chemiluminescent oligonucleotide probes. AIDS Res Hum Retroviruses (1990) 1.33
The value of urethral sphincter electromyography in the differential diagnosis of parkinsonism. Br J Urol (1989) 1.32
Individual motor unit analysis in the diagnosis of disorders of urethral sphincter innervation. J Neurol Neurosurg Psychiatry (1984) 1.28
Consensus statement on the diagnosis of multiple system atrophy. J Auton Nerv Syst (1998) 1.25
Effects of homologues and analogues of palmitoylethanolamide upon the inactivation of the endocannabinoid anandamide. Br J Pharmacol (2001) 1.25
Assessment of demyelination, edema, and gliosis by in vivo determination of T1 and T2 in the brain of patients with acute attack of multiple sclerosis. Magn Reson Med (1989) 1.23
Nerve conduction studies, skeletal muscle EMG, and sphincter EMG in multiple system atrophy. J Neurol Neurosurg Psychiatry (1995) 1.22
Urinary symptoms and the neurological features of bladder dysfunction in multiple sclerosis. J Neurol Neurosurg Psychiatry (1993) 1.20
Value of sphincter electromyography in the diagnosis of multiple system atrophy. Muscle Nerve (1997) 1.15
Intravesical capsaicin as a treatment for refractory detrusor hyperreflexia: a dual center study with long-term followup. J Urol (1997) 1.14
Expression of the mitotic motor protein Eg5 in postmitotic neurons: implications for neuronal development. J Neurosci (1998) 1.14
Pasteurella multocida: diseases and pathogenesis. Curr Top Microbiol Immunol (2012) 1.13
Acute urinary retention: an unusual presentation of a spinal arteriovenous malformation. BJU Int (1999) 1.13
Neural control of the lower urinary and gastrointestinal tracts: supraspinal CNS mechanisms. Neurourol Urodyn (2010) 1.12
An apparent autocrine mechanism amplifies the dexamethasone- and retinoic acid-induced expression of mouse lipocalin-encoding gene 24p3. Gene (1996) 1.10
Capsaicin receptor VR1 and ATP-gated ion channel P2X3 in human urinary bladder. BJU Int (2001) 1.10
Stereotaxic thalamotomy in 55 cases of dystonia. Brain (1983) 1.09
Changes in peripheral nerve fibres distal to a constriction. J Neurol Sci (1982) 1.09
Newcastle thyrotoxicosis index. Lancet (1970) 1.09
Pontine pathology and voiding dysfunction. Br J Urol (1992) 1.09
Chronic fatigue: electromyographic and neuropathological evaluation. J Neurol (1993) 1.08
The effect of age on the activity and molecular properties of human brain monoamine oxidase. J Neural Transm (1980) 1.08
Immediate and short-term benefit of multilesion coronary angioplasty: influence of degree of revascularization. J Am Coll Cardiol (1985) 1.07
The nature of the inhibition of rat liver monoamine oxidase types A and B by the acetylenic inhibitors clorgyline, l-deprenyl and pargyline. Biochem Pharmacol (1982) 1.07
Abnormal electromyographic activity (decelerating burst and complex repetitive discharges) in the striated muscle of the urethral sphincter in 5 women with persisting urinary retention. Br J Urol (1985) 1.07
Characterization of palmitoylethanolamide transport in mouse Neuro-2a neuroblastoma and rat RBL-2H3 basophilic leukaemia cells: comparison with anandamide. Br J Pharmacol (2001) 1.07
Prospective evaluation of clinical criteria to select older persons with acute medical illness for care in a hypothetical home hospital. J Am Geriatr Soc (1997) 1.07
The deamination of dopamine by human brain monoamine oxidase. Specificity for the two enzyme forms in seven brain regions. Naunyn Schmiedebergs Arch Pharmacol (1983) 1.07
Avoidance and confrontation of painful, back-straining movements in chronic back pain patients. Behav Modif (1998) 1.06
Long-term effectiveness of sacral nerve stimulation for refractory urge incontinence. Eur Urol (2001) 1.06
Concentration dependence of the oxidation of tyramine by the two forms of rat liver mitochondrial monoamine oxidase. Biochem Pharmacol (1981) 1.05
Deamination of 5-hydroxytryptamine by both forms of monoamine oxidase in the rat brain. J Neurochem (1982) 1.04
Plasma exchange combined with azathioprine in multiple sclerosis using serial gadolinium-enhanced MRI to monitor disease activity: a randomized single-masked cross-over pilot study. Neurology (1996) 1.03
Inhibition of rat C6 glioma cell proliferation by endogenous and synthetic cannabinoids. Relative involvement of cannabinoid and vanilloid receptors. J Pharmacol Exp Ther (2001) 1.02
Trial of an asthma action plan in the Maori community of the Wairarapa. N Z Med J (1993) 1.02
Outcome of microdissection TESE compared with conventional TESE in non-obstructive azoospermia: a systematic review. Andrology (2013) 1.01
Intravesical capsaicin for neurogenic bladder dysfunction. Lancet (1992) 1.01
Vitamin D status and recurrent preterm birth: a nested case-control study in high-risk women. BJOG (2012) 1.00
EAU guidelines on chronic pelvic pain. Eur Urol (2004) 0.99
Acceptability to patients of a home hospital. J Am Geriatr Soc (1998) 0.98
Effect of carotid ligation on cerebral blood flow in baboons. I. Response to altered arterial PCO2. J Neurol Neurosurg Psychiatry (1973) 0.97
Attentional disruption is enhanced by the threat of pain. Behav Res Ther (1998) 0.97
How to recognize patients with parkinsonism who should not have urological surgery. Br J Urol (1997) 0.97
Randomized controlled trial of Sativex to treat detrusor overactivity in multiple sclerosis. Mult Scler (2010) 0.97
Characteristics and causes of penetrating eye injuries reported to the National Eye Trauma System Registry, 1985-91. Public Health Rep (1993) 0.97
The disruptive nature of pain: an experimental investigation. Behav Res Ther (1997) 0.97
Micturition disturbance in Parkinson's disease. Br J Urol (1985) 0.97
Evidence of CNS impairment in HIV infection: clinical, neuropsychological, EEG, and MRI/MRS study. J Neurol Neurosurg Psychiatry (1998) 0.96
Erectile and urinary dysfunction may be the presenting features in patients with multiple system atrophy: a retrospective study. Int J Impot Res (2003) 0.96
Isolated urinary retention in young women, or Fowler's syndrome. Clin Auton Res (2001) 0.95
Predictors of bacteremia in febrile children 3 to 36 months of age. Pediatrics (2000) 0.95
Prevalence of bowel dysfunction in patients with multiple sclerosis and bladder dysfunction. J Neurol (1995) 0.94
Habituation and the interference of pain with task performance. Pain (1997) 0.94
Non-typhi Salmonella bacteremia in children. Pediatr Infect Dis J (1999) 0.93
Penetrating eye injuries related to assault. The National Eye Trauma System Registry. Arch Ophthalmol (1992) 0.92
Inhibition of the cellular uptake of anandamide by genistein and its analogue daidzein in cells with different levels of fatty acid amide hydrolase-driven uptake. Br J Pharmacol (2007) 0.92
Sacral neuromodulation and pregnancy. J Urol (2002) 0.92
The micturition switch and its forebrain influences. Acta Physiol (Oxf) (2012) 0.91
Effects of pH on the inhibition of fatty acid amidohydrolase by ibuprofen. Br J Pharmacol (2001) 0.90
Acquisition and extinction of somatic symptoms in response to odours: a Pavlovian paradigm relevant to multiple chemical sensitivity. Occup Environ Med (1999) 0.90
Antibodies to protein P in systemic lupus erythematosus. Ann Rheum Dis (1992) 0.90
Sacral neuromodulation for women with Fowler's syndrome. Eur Urol (2000) 0.90
Decelerating burst and complex repetitive discharges in the striated muscle of the urethral sphincter, associated with urinary retention in women. J Neurol Neurosurg Psychiatry (1985) 0.90
A minimally invasive technique for outpatient local anaesthetic administration of intradetrusor botulinum toxin in intractable detrusor overactivity. BJU Int (2003) 0.88
The 'specific' tyrosine kinase inhibitor genistein inhibits the enzymic hydrolysis of anandamide: implications for anandamide uptake. Br J Pharmacol (2007) 0.88